Humanigen (OTCQB: HGEN) is a biopharmaceutical company pursuing cutting-edge science to develop its proprietary monoclonal antibodies for immunotherapy and oncology treatments. The company’s focus is on making chimeric antigen receptor T-cell (CAR-T) therapy safer, better and more routine. CAR-T therapy uses a patient’s immune system to recognize and attack a specific tumor antigen. Clinical trials have shown high remission rates, including remission in radiation- and chemo-unresponsive patients but at high risk. The company is working to reduce these risks and improve the efficacy of CAR-T therapies. For more information, visit the company’s website at www.humanigen.com.
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, please visit https://www.networknewswire.com